Carolyn Myers Insider Profile

4 Followers
Carolyn Myers, Director at Mayne Pharma Group, holds 1.63M shares in FendX Technologies, Inc. (Ticker: TSE:FNDX), holds 20.00K shares in Mayne Pharma Group (Ticker: MAYNF). Most recently, Carolyn Myers Bought ― shares of FendX Technologies, Inc. on Mar 28, 2024 for an estimated value of 25.00K.
tipranks
Carolyn  Myers

Carolyn Myers
Mayne Pharma Group (MAYNF)
Director

Ranked #32,248 out of 98,042 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+40.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$344K
86.26%
13.74%
A breakdown of Carolyn Myers's holdings

Insider Roles

FendX Technologies, Inc.
(FNDX)
Senior Officer
Mayne Pharma Group
(MAYNF)
Director
Roles that Carolyn Myers holds in companies

Most Profitable Insider Trade

Stock:
Mayne Pharma Group
(MAYNF)
Rating:Informative Buy
Date:Mar 31, 2023 - Mar 31, 2024
Return:+85.00%
The most profitable trade made by Carolyn Myers

Carolyn Myers's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mayne Pharma Group
Mar 31, 2023
Director
Informative Buy
74.53K
$62.10K
FendX Technologies, Inc.
Mar 28, 2024
Senior Officer
Informative Buy
25.00K
C$390.00K
List of latest transactions for each holding click on a transaction to see Carolyn Myers's performance on stock

Carolyn Myers insider profile FAQ

What is the percentage of profitable transactions made by Carolyn Myers?
The percentage of profitable transactions made by Carolyn Myers is 50%.
    What is the average return per transaction made by Carolyn Myers?
    The average return per transaction made by Carolyn Myers is 40.60%.
      What stocks does Carolyn Myers hold?
      Carolyn Myers holds: MAYNF, TSE:FNDX stocks.
        What was Carolyn Myers’s latest transaction?
        Carolyn Myers latest transaction was an Informative Buy of C$25.00K.
          What was Carolyn Myers's most profitable transaction?
          Carolyn Myers’s most profitable transaction was an Informative Buy of MAYNF stock on March 31, 2023. The return on the trade was 85.00%.
            What is Carolyn Myers's role in Mayne Pharma Group?
            Carolyn Myers's role in Mayne Pharma Group is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.